Department of Infectious Diseases, The Prince Charles Hospital, Metro North Hospital and Health Service, Brisbane, Queensland, Australia.
Adult Intensive Care Services, The Prince Charles Hospital, Metro North Hospital and Health Service, Brisbane, Queensland, Australia.
Infect Dis Health. 2021 Feb;26(1):48-54. doi: 10.1016/j.idh.2020.09.001. Epub 2020 Sep 19.
Patients suffering out-of-hospital cardiac arrest (OHCA) are at an increased risk of aspiration pneumonitis and development of subsequent aspiration pneumonia. The diagnostic uncertainty in this context can lead to a large proportion receiving broad spectrum antibiotics.
This was a three-year, retrospective cohort study of consecutive patients admitted with OHCA. Data were collected in an Australian tertiary centre intensive care unit (ICU) between December 2016-December 2019. We assessed the incidence of Ventilator associated pneumonia (VAP), admission Clinical Pulmonary Infection Scores (CPIS) in patients with OHCA and its' association with VAP at day 3 [1]. We also assessed antibiotics prescribing (timing of initiation and drug choice) and intensive care mortality relative to the day 1 CPIS.
Over the three years, 100 patients were admitted with OHCA. The incidence of VAP was 6%. The CPIS on admission was not associated with development of VAP at day 3 (p = 0.75) and no significant association was found between choice of antibiotic regimens and VAP incidence. Timing of initiation of antibiotics was associated with VAP (12hrs vs 48hrs, p = 0.035) but not the choice of antibiotic (penicillin and cephalosporins vs antipseudomonal antibiotics). CPIS score at day 1 was not associated with ICU mortality in a multivariate analysis.
We demonstrated a very low incidence of VAP in OHCA patients in comparison to published studies. In this context, there was no evidence for an association between CPIS score and VAP at day 3. The CPIS may have utility as a decision support tool for targeted antibiotic prescribing in this cohort.
患有院外心脏骤停 (OHCA) 的患者患吸入性肺炎和随后发生吸入性肺炎的风险增加。在这种情况下,诊断的不确定性可能导致很大一部分患者接受广谱抗生素治疗。
这是一项为期三年的回顾性队列研究,连续纳入因 OHCA 入院的患者。数据于 2016 年 12 月至 2019 年 12 月在澳大利亚一家三级中心重症监护病房 (ICU) 收集。我们评估了呼吸机相关性肺炎 (VAP) 的发生率、OHCA 患者的入院临床肺部感染评分 (CPIS) 及其与第 3 天 VAP 的关系[1]。我们还评估了抗生素的使用(开始使用的时机和药物选择)以及相对于第 1 天 CPIS 的 ICU 死亡率。
在这三年中,有 100 名患者因 OHCA 入院。VAP 的发生率为 6%。入院时的 CPIS 与第 3 天的 VAP 发展无关 (p = 0.75),抗生素方案的选择与 VAP 发生率之间也没有发现显著关联。抗生素使用的起始时间与 VAP 相关(12 小时与 48 小时,p = 0.035),但抗生素的选择(青霉素和头孢菌素与抗假单胞菌抗生素)无关。在多变量分析中,CPIS 评分在第 1 天与 ICU 死亡率无关。
与已发表的研究相比,我们在 OHCA 患者中发现 VAP 的发生率非常低。在这种情况下,CPIS 评分与第 3 天的 VAP 之间没有证据表明存在关联。CPIS 可能作为一种决策支持工具,用于该队列的靶向抗生素治疗。